Jane Rah

Jane Rah is the current VP of Finance and Accounting at Lunit. Jane has also held the position of Finance Sr. Manager at Amgen from June 2016 to August 2021. In this role, they were responsible for overseeing the finance for a number of products, including Oncology portfolio, Blincyto, Kyprolis, the Bone Franchise, the Biosimilar business unit, and Aimovig.

Jane is a highly skilled financial analyst with a keen eye for detail. Jane has a proven track record in managing large budgets and has a deep understanding of financial planning and forecasting. Jane is a strong leader and has a proven ability to work collaboratively with cross-functional teams.

Jane Rah is a highly accomplished finance professional with over 20 years of experience in the industry. Jane holds a Bachelor of Arts in Economics from the University of California, Berkeley and a Master of Business Administration from the University of Southern California.

Jane Rah's educational career includes receiving a Master of Business Administration (M.B.A.) from the UCLA Anderson School of Management, a Master's Degree in Accounting from the University of Virginia, and a Bachelor's Degree in Commerce (Accounting & Finance) and Economics from the University of Virginia. Jane is also certified as a public accountant from the Virginia Board of Accountancy.

Some of their coworkers include Ryan Choi - VP, Clinical Research, Medical Affairs Division, Radiology Group, Eunsu Jamie Park - VP, Product, Innovation Division, Common Group, and Donggeun Yoo - Co-founder & Chief of Research. Jane Rah reports to Beomseok Brandon Suh, CEO.